AZD5438

Alias: AZD5438; AZD-5438; AZD 5438
Cat No.:V1555 Purity: ≥98%
AZD5438 (AZD-5438;AZD 5438) is a novel, potent and selective small molecule inhibitor of cyclin-dependent kinase (CDK) 1, 2 and 9 with potential antineoplastic activity.
AZD5438 Chemical Structure CAS No.: 602306-29-6
Product category: CDK
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
5mg
10mg
25mg
50mg
100mg
250mg
500mg
Other Sizes

Other Forms of AZD5438:

  • AZD-5438 HCl
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

AZD5438 (AZD-5438; AZD 5438) is a novel, potent and selective small molecule inhibitor of cyclin-dependent kinase (CDK) 1, 2 and 9 with potential antineoplastic activity. The inhibitory concentrations of 16 nmol/L, 6 nmol/L, and 20 nmol/L, respectively, are found to inhibit CDK1/2/9. In multiple human tumor cell lines, AZD5438 exhibited noteworthy anti-proliferative activity, with an IC50 ranging from 0.2 μmol/L to 1.7 μmol/L. This resulted in the inhibition of cell cycling at the G2-M, S, and G1 phases as well as the phosphorylation of select proteins, such as CDK substrates pRb, nucleolin, protein phosphatase 1a, and RNA polymerase II COOH-terminal domain.

Biological Activity I Assay Protocols (From Reference)
Targets
cdk2-cyclin E (IC50 = 6 nM); cdk2-cyclin A (IC50 = 45 nM); cdk5-p25 (IC50 = 14 nM); cdk1-cyclin B1 (IC50 = 16 nM); cdk9-cyclin T (IC50 = 20 nM); cdk6-cyclin D3 (IC50 = 21 nM); cdk4-cyclin D1 (IC50 = 449 nM); cdk7-cyclin H (IC50 = 821 nM)
ln Vitro

AZD5438 demonstrates a strong inhibitory effect on the activity of cyclin-dependent kinases, with IC50 values of 6 nM, 45 nM, 16 nM, 21 nM, and 20 nM, respectively, for cyclin E-cdk2, cyclin A-cdk2, cyclin B1-cdk1, cyclin D3-cdk6, and cyclin T-cdk9. Furthermore, with IC50 values of 14 nM and 17 nM, respectively, AZD5438 suppresses the kinase activity of glycogen synthase kinase 3β and p25-cdk5. (Source: ) By preventing the phosphorylation of CDK-dependent substrates, AZD5438 causes cell cycle arrest. It also demonstrates broad antiproliferative activity against various tumor cell lines, such as lung, colorectal, breast, prostate, and hematologic tumors, with an IC50 ranging from 0.2 μM (MCF-7) to 1.7 μM (ARH-77).[1]

ln Vivo
When AZD5438 is taken orally in vivo, human tumor xenografts derived from a variety of cancer types, including breast, colon, lung, prostate, and ovarian, show statistically significant inhibition against growth, with a maximum tumor growth index (TGI) ranging from 38% to 153%. (Source: ) AZD5438 inhibits a number of cell cycle proteins in the SW620 xenograft model, including phH3, phosphonucleolin, PP1a, and multiple phospho-pRb epitopes. These effects are dose-dependent.[1]
Enzyme Assay
A scintillation proximity assay is used to test AZD5438's capacity to inhibit CDK activity. It involves using recombinant CDK-cyclin complexes of cyclin-Ecdk2, cdk2-cyclin A, cdk4-cyclin D, and recombinant retinoblastoma substrate (amino acids 792-928) or cdk1-cyclin B1 with a peptide substrate derived from the in vitro p34cdc2 phosphorylation site of histone H1 (biotin-X-Pro-Lys-Thr-Pro-Lys-Lys-Ala-Lys-Lys-Leu). Using peptide substrate (AKKPKTPKKAKKLOH), AZD5438's activity against recombinant cdk5/p25 is assessed in a scintillation proximity assay-based assay at 2 μM ATP. By using human purified glycogen synthase kinase 3βenzyme and eukaryotic initiation factor 2B substrate (at 1 μM ATP), the scintillation proximity assay is used to determine the inhibition of glycogen synthase kinase 3β activity. AZD5438 is subjected to a kinase selectivity screening service in which it is screened against cdk6-cyclin D3, cdk7-cyclin H/MAT1 (cdk activating kinase complex), and cdk9-cyclin T.
Cell Assay
Solid tumor cell lines are used to test AZD5438. In summary, AZD5438 is added to cells at different concentrations and incubated for 48 hours. After the incubation period, 5-bromo-2′-deoxyuridine (BrdUrd) is pulsed into the cells, and the quantity of DNA synthesis is quantified. Specifically, cell death has no bearing on the IC50 for proliferation inhibition. The following protocol is used to seed multiple myeloma cell lines into 96-well plates: RPMI 1640 supplemented with 10% FCS and glutamine, followed by a 72-hour dose of AZD5438. AlamarBlue is used to measure cell growth, and GI50 values are computed using the pretreatment control values.
Animal Protocol
Every human tumor xenograft, with the exception of HX147, is created by subcutaneously injecting 100 μL of tumor cells (a mixture of 1×106 and 1×107 cells mixed 1:1 with Matrigel). The origin of HX147 tumors is fragment implants (1 mm3 pieces) from tumors removed from mice that were first injected subcutaneously with 1×107 cells. Prior to being implanted for antitumor work, these tumor fragments undergo three passages through mice. As previously mentioned, tumor volumes are computed, tumor measurements are made up to three times a week using calipers, and the data are plotted as the geometric mean for each group versus time. Tumors that reach a mean size of roughly >0.2 cm3 in mice and >0.5 cm3 in rats are the triggers for randomization of animals into treatment groups (usually n=10). Hydroxy-propyl-methyl-cellulose is used to prepare AZD5438. Oral gavage of AZD5438 (37.5-75 mg/kg) or vehicle control is administered once or twice daily to animals for approximately three weeks in each scenario. As previously mentioned, the tumor volume and percentage tumor growth inhibition (% TGI) are computed. Any variation in tumor volume is statistically analyzed using the standard t test, with a significance level of P<0.05.
References

[1]. Mol Cancer Ther . 2009 Jul;8(7):1856-66.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C18H21N5O2S
Molecular Weight
371.46
Exact Mass
371.14
Elemental Analysis
C, 58.20; H, 5.70; N, 18.85; O, 8.61; S, 8.63
CAS #
602306-29-6
Appearance
Solid powder
SMILES
CC1=NC=C(N1C(C)C)C2=NC(=NC=C2)NC3=CC=C(C=C3)S(=O)(=O)C
InChi Key
WJRRGYBTGDJBFX-UHFFFAOYSA-N
InChi Code
InChI=1S/C18H21N5O2S/c1-12(2)23-13(3)20-11-17(23)16-9-10-19-18(22-16)21-14-5-7-15(8-6-14)26(4,24)25/h5-12H,1-4H3,(H,19,21,22)
Chemical Name
4-(2-methyl-3-propan-2-ylimidazol-4-yl)-N-(4-methylsulfonylphenyl)pyrimidin-2-amine
Synonyms
AZD5438; AZD-5438; AZD 5438
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: ~74 mg/mL (~199.2 mM)
Water: <1 mg/mL
Ethanol: ~74 mg/mL (~199.2 mM)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.6921 mL 13.4604 mL 26.9208 mL
5 mM 0.5384 mL 2.6921 mL 5.3842 mL
10 mM 0.2692 mL 1.3460 mL 2.6921 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Clinical Trial Information
NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT00088790 Completed Drug: AZD5438 Neoplasms AstraZeneca July 2004 Phase 1
Biological Data
Contact Us